A Randomized Phase 3 Study of Two Doses of Alimta [Pemetrexed] in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 01 May 2008 Results published in the Annals of Oncology.
- 06 Sep 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History